Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Glioma
|
353 | 0.559 | 0.760 | 1 | 226367601 | missense variant | A/G | snv | 0.21 | 0.15 | 0.080 | 1.000 | 8 | 2009 | 2019 | ||||
Breast Carcinoma
|
2793 | 0.559 | 0.760 | 1 | 226367601 | missense variant | A/G | snv | 0.21 | 0.15 | 0.060 | 0.667 | 6 | 2008 | 2019 | ||||
Malignant neoplasm of breast
|
3417 | 0.559 | 0.760 | 1 | 226367601 | missense variant | A/G | snv | 0.21 | 0.15 | 0.060 | 0.667 | 6 | 2008 | 2019 | ||||
Malignant Neoplasms
|
1641 | 0.559 | 0.760 | 1 | 226367601 | missense variant | A/G | snv | 0.21 | 0.15 | 0.060 | 0.833 | 6 | 2009 | 2017 | ||||
Primary malignant neoplasm
|
1374 | 0.559 | 0.760 | 1 | 226367601 | missense variant | A/G | snv | 0.21 | 0.15 | 0.060 | 0.833 | 6 | 2009 | 2017 | ||||
Malignant neoplasm of stomach
|
615 | 0.559 | 0.760 | 1 | 226367601 | missense variant | A/G | snv | 0.21 | 0.15 | 0.050 | 0.800 | 5 | 2009 | 2014 | ||||
Stomach Carcinoma
|
652 | 0.559 | 0.760 | 1 | 226367601 | missense variant | A/G | snv | 0.21 | 0.15 | 0.050 | 0.800 | 5 | 2009 | 2014 | ||||
Cervix carcinoma
|
283 | 0.559 | 0.760 | 1 | 226367601 | missense variant | A/G | snv | 0.21 | 0.15 | 0.030 | 1.000 | 3 | 2012 | 2017 | ||||
Colorectal Carcinoma
|
1962 | 0.559 | 0.760 | 1 | 226367601 | missense variant | A/G | snv | 0.21 | 0.15 | 0.030 | 0.667 | 3 | 2010 | 2014 | ||||
Diabetes Mellitus, Non-Insulin-Dependent
|
2672 | 0.559 | 0.760 | 1 | 226367601 | missense variant | A/G | snv | 0.21 | 0.15 | 0.030 | 1.000 | 3 | 2012 | 2016 | ||||
Malignant neoplasm of lung
|
1142 | 0.559 | 0.760 | 1 | 226367601 | missense variant | A/G | snv | 0.21 | 0.15 | 0.030 | 1.000 | 3 | 2014 | 2019 | ||||
Brain Neoplasms
|
204 | 0.559 | 0.760 | 1 | 226367601 | missense variant | A/G | snv | 0.21 | 0.15 | 0.020 | 1.000 | 2 | 2016 | 2019 | ||||
Carcinoma of lung
|
1204 | 0.559 | 0.760 | 1 | 226367601 | missense variant | A/G | snv | 0.21 | 0.15 | 0.020 | 1.000 | 2 | 2015 | 2019 | ||||
cervical cancer
|
268 | 0.559 | 0.760 | 1 | 226367601 | missense variant | A/G | snv | 0.21 | 0.15 | 0.020 | 1.000 | 2 | 2013 | 2017 | ||||
Coronary Artery Disease
|
1577 | 0.559 | 0.760 | 1 | 226367601 | missense variant | A/G | snv | 0.21 | 0.15 | 0.020 | 1.000 | 2 | 2012 | 2017 | ||||
Malignant neoplasm of prostate
|
1082 | 0.559 | 0.760 | 1 | 226367601 | missense variant | A/G | snv | 0.21 | 0.15 | 0.020 | 1.000 | 2 | 2004 | 2005 | ||||
Malignant neoplasm of thyroid
|
103 | 0.559 | 0.760 | 1 | 226367601 | missense variant | A/G | snv | 0.21 | 0.15 | 0.020 | 1.000 | 2 | 2012 | 2018 | ||||
Malignant tumor of cervix
|
245 | 0.559 | 0.760 | 1 | 226367601 | missense variant | A/G | snv | 0.21 | 0.15 | 0.020 | 1.000 | 2 | 2013 | 2017 | ||||
Primary malignant neoplasm of lung
|
981 | 0.559 | 0.760 | 1 | 226367601 | missense variant | A/G | snv | 0.21 | 0.15 | 0.020 | 1.000 | 2 | 2015 | 2019 | ||||
Prostate carcinoma
|
1168 | 0.559 | 0.760 | 1 | 226367601 | missense variant | A/G | snv | 0.21 | 0.15 | 0.020 | 1.000 | 2 | 2004 | 2005 | ||||
Thyroid carcinoma
|
145 | 0.559 | 0.760 | 1 | 226367601 | missense variant | A/G | snv | 0.21 | 0.15 | 0.020 | 1.000 | 2 | 2012 | 2018 | ||||
Thyroid Neoplasm
|
135 | 0.559 | 0.760 | 1 | 226367601 | missense variant | A/G | snv | 0.21 | 0.15 | 0.020 | 1.000 | 2 | 2012 | 2018 | ||||
Adenocarcinoma
|
168 | 0.559 | 0.760 | 1 | 226367601 | missense variant | A/G | snv | 0.21 | 0.15 | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||
Adenocarcinoma of lung (disorder)
|
563 | 0.559 | 0.760 | 1 | 226367601 | missense variant | A/G | snv | 0.21 | 0.15 | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||
Adult Non-Hodgkin Lymphoma
|
39 | 0.559 | 0.760 | 1 | 226367601 | missense variant | A/G | snv | 0.21 | 0.15 | 0.010 | 1.000 | 1 | 2010 | 2010 |